.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Cervical cancer remains a major public health challenge in India, causing around 80,000 annual deaths. Fortunately, a newly validated indigenous HPV test offers a major breakthrough in affordable diagnostics. The World Health Organization (WHO) recommends transitioning to molecular testing to eliminate this disease. Therefore, integrating these cost-effective tools is critical for expanding screening coverage nationwide.
Currently, visual inspection with acetic acid (VIA) is the standard method in many areas. However, this screening method has subjective limitations and low sensitivity. Although global gold-standard DNA tests are highly accurate, they remain too expensive for last-mile clinical settings. Consequently, healthcare providers struggle to screen women in remote villages. This new indigenous HPV test addresses these gaps by providing highly reliable results at a fraction of the cost.
A recent multicentre study evaluated Indian HPV DNA testing platforms under international standards. Specifically, premier institutions like AIIMS New Delhi and ICMR conducted this research. The investigators collaborated closely with the WHO International Agency for Research on Cancer (IARC). Ultimately, the study confirmed that these tests achieve clinical validation comparable to global standards. Thus, India can now deploy these tools in national screening programs with high confidence.
These molecular platforms target the eight most common high-risk HPV types. Moreover, district-level personnel can run them easily since they already use similar PCR systems. Additionally, clinicians can adopt same-day treatment protocols for patients who test positive. In the future, self-sampling and high-throughput adaptations will further enhance patient access. Consequently, this diagnostic innovation will significantly accelerate cervical cancer elimination goals.
Q1: Why is the indigenous HPV test preferred over traditional VIA screening?
The molecular test specifically detects high-risk human papillomavirus DNA with objective clinical accuracy. Conversely, traditional visual inspection with acetic acid relies heavily on provider interpretation and has lower sensitivity.
Q2: At what ages should women undergo HPV DNA screening?
According to the WHO elimination strategy, women should undergo screening at age 35 and again at age 45. Using validated tests, these two rounds are sufficient to achieve elimination goals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India has validated its first indigenous, point-of-care HPV DNA tests to screen for high-risk HPV genotypes. Developed in collaboration with AIIMS, ICMR, and the WHO-IARC, these affordable molecular platforms aim to improve cervical cancer screening access in low-resource and district-level healthcare facilities.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
